Durable Medical Equipment (DME) Market Growth, Demand and Challenges of the Key Industry Players 2023-28
                     Global Durable Medical 
Equipment (DME) Market 
Research and Forecast 
Report 2023-2028
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
Acco r d ing  t o  t he  l a t es t  r epo r t  by  I M ARC  G r ou p ,  t i t l e d  " Dura b l e  M ed i c a l  Equ i pm ent  
( DM E)  M ark e t :  G l o ba l  I ndus t ry  T rend s ,  S hare ,  S i z e ,  G row t h ,  O pp or t un i t y  and  
For ec as t  2023 - 2028 , "  t he  g loba l  du r a b le  m e d ica l  eq u ipm en t  ( D M E)  m ar ke t  s i ze  
r eac hed  US$  2 04 . 2  B i l l i on  i n  20 22 .
Dur ab le  m ed ica l  equ ip m en t  i s  us ed  i n  c l i n i cs ,  h osp i t a l s ,  and  hom e  ca r e  se t t i ng s  t o  
Report p r ov ide  a  be t t e r  q ua l i t y  o f  l i f e  t o  pa t i en t s  w i t h  deb i l i t a t i ng  m e d ica l  co nd i t i on s ,  
i l l nes ses ,  o r  i n j u r ie s .  I t  i s  cov e r ed  i n  m a ny  i nsu r ance  po l i c i e s  and  i nc lude s  i r on  
Highlight and l ungs ,  c a t he t e r s ,  CP AP,  hos p i t a l  beds ,  i r on  l un gs ,  ne bu l i ze r s ,  oxyge n  t e n t s ,  b loo d -t es t i ng  s t r i ps  and  b lood  g luco se  m on i t o r s ,  a nd  w hee lch a i r s .  
I t  i s  f u r n i she d  on  a  r en t a l  bas i s  f o r  a  l ong  du r a t i o n  o r  pu r chase d .  I t  i s  p r esc r ib ed  by  
Description a  ph ys i c ian  o r  hea l t hca r e  p r o v ide r  t o  accom m o da t e  a  p a t i en t ' s  t em p or a r y  d i sab i l i t y ,  
as  i n  t h e  c ase  o f  a  whee lc ha i r  o r  c r u t ch es  f o r  a  r ecove r ing  pa t i en t ,  o r  as  p a r t  o f  a  
pa t i en t ' s  l ong - t e r m  ca r e  p lan  f o r  t he i r  ch r on i c  o r  l i f e - l im i t i ng  c ond i t i o n ,  suc h  as  a  
m ec han ic a l  ven t i l a t o r  f o r  a  p a t i en t  w i t h  adv anced  l ung  d i se ase .
Reque st  f o r  a  PDF  sam pl e  o f  t h i s  re por t :  
h t t p s : / / www. im ar c g r ou p . com / du r ab le - m ed ic a l - eq u ipm e n t - m ar ke t / r e ques t sam p le
Report Description
Gl o b a l  D u r ab l e  Me d i c a l  E q u ip m e n t  ( D M E )  M ar k e t  T r e n d s :
T he  g l o b a l  m a r k e t  i s  m a j o r l y  d r i v e n  b y  t he  i nc r e a s i n g  i n c i d e n ce s  o f  c a n c e r ,  c a r d i a c  d i so r d e rs ,  ne u r o l og i c a l  c o nd i t i o n s ,  a n d  
gy n e c o l og i c a l  c o mp l i c a t i on s .  I n  l i n e  w i t h  t h i s ,  b e t te r  c o v e r a g e  a n d  f av o r a b l e  r e i mb u r s e me n t  p o l i c i e s  fo r  d u r ab l e  me d i c a l  
eq u i p me n t  p r o d uc t s  a r e  e x pe c t e d  t o  p os i t i v e l y  i n f l u en c e  t h e  p r o d u c t  de m a n d .  F u r t he r mo r e ,  t h e  r i s i n g  nu m b e r  o f  e l d e r l y  c a r e  
ce n t e r s  d u e  to  t he  e x p an d i n g  ge r i a t r i c  p o p u l a t i o n  b as e  a nd  i t s  s u s c e p t i b i l i t y  t o  s k e l e t a l ,  c a rd i a c ,  a n d  n e u r o l o g i c a l  c o n d i t i o n s ,  
w h i c h  a ug m e n ts  t h e  n e e d  f o r  l o ng - t e rm  c a re  a n d  r e c o v e r y ,  a r e  a n t i c i p a t ed  t o  i nc r e a se  t h e  d e m a nd  f o r  D M E  p r o d uc t s .  
Mo r e ov e r ,  t he  i n t r o du c t i o n  o f  t e c hn o l o g i c a l l y  a d v a nc e d  p r o d u c t s  w i t h  i m p ro v e d  p a t i e n t  c o mf o r t  a n d  po r t a b i l i t y  i s  c r e a t i n g  a  
po s i t i v e  o u t l o o k  f o r  t h e  m a r ke t .  A d d i t i o n a l l y ,  t h e  e sc a l a t i ng  p r e f e r e n c e  fo r  a v a i l i ng  p os t - o pe r a t i v e  a n d  l o n g - t e r m  ca r e  a t  ho m e  
i s  p r o v i d i n g  a  bo o s t  t o  t h e  m a rk e t .  S o me  o f  t h e  o t h e r  f ac t o r s  d r i v i ng  t he  ma r k e t  e x p an s i o n  i nc l u d e  c o n t i n u a l  t e c h n o l o g i c a l  
ad v a n ce m e n ts  i n  D ME ,  i n f l a t i n g  d i s p o s ab l e  i n c om e s  o f  c o ns u m er s ,  a nd  r a p i d  a d o p t i on  o f  h o m e- b a s e d  m o n i to r i n g  d e v i c e s .
L o o k i n g  f o rw a r d ,  t h e  m ar k e t  i s  an t i c ip a t e d  t o  r e a c h  a  v a l u e  o f  U S $  2 9 4 . 4  B i l l io n  b y  2 02 8 ,  ex h i b i t i n g  a  C A G R  o f  6 .2 %  
d u r i n g  2 0 2 3 -2 0 2 8 .
V i e w  R e p o r t  T O C ,  F i g u r e s  a n d  T a b l e s :  h t t p s : / / w ww . i m a r c g ro u p . co m / d u ra b l e - m e d i ca l - e q u i p m en t - m ar k e t
Breakup by Product:
• Personal  Mobi l i ty  Devices
o Wheelchairs
o Scooters
o Walker and Rol lators
o Cranes and Crutches
o Door Openers
o Others
Report • Bathroom Safety Devices and Medical  Furniture
Segmentation o Commodes and Toi lets
o Mattress and Bedding Devices
• Monitor ing and Therapeutic  Devices
o Blood Sugar Monitors
o Cont inuous Pass ive Mot ion (CPM)
o In fus ion Pumps
o Nebul izers 
o Oxygen Equipment
o Cont inuous Posit ive Airway Pressure 
(CPAP)
o Suct ion Pumps
o Tract ion Equipment
o Others  
Breakup by End Use:
• Hospita l
• Nurs ing Homes
Report • Home Healthcare
Segmentation • Others
Breakup by Region:
• North Amer ica
• Asia-Pacifi c
• Europe
• Lat in Amer ica
• Middle  East  and Afr ica
• ArjoHuntle igh
• Becton
• Dick inson and Company
• General  E lectr ic  Company
Competitive • GF Health  Products Inc.
•
Landscape Hi l l -Rom Services Inc. ,
• Invacare Corporat ion
with Key • Koninkl i jke Ph i l ips NV
Players • Medical  Device Depot Inc.
• Medl ine Industr ies Inc.
• Medtronic  PLC
• Omron Corporat ion
• Siemens Health ineers AG (S iemens AG)
• Stryker Corporat ion.
What was the size of the global Durable Medical 
Equipment (DME) market in 2022?
What is the expected growth rate of the global 
Durable Medical Equipment (DME) market during 
2023-2028?
What are the key factors driving the global Durable 
Key Medical Equipment (DME) market?
Questions What has been the impact of COVID-19 on the 
global Durable Medical Equipment (DME) market?
Answered in 
What is the breakup of the global Durable Medical 
the Report Equipment (DME) market based on the product?
What is the breakup of the global Durable Medical 
Equipment (DME) market based on the end use?
What are the key regions in the global Durable 
Medical Equipment (DME) market?
Who are the key players/companies in the global 
Durable Medical Equipment (DME) market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
        2 . 4 . 1     B o t t o m - U p  A p p r o a c h
Table of         2 . 4 . 2     T o p - D o w n  A p p r o a c h    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
    4 . 1     O v e r v i e w
Contents     4 . 2     K e y  I n d u s t r y  T r e n d s5     G l o b a l  D u r a b l e  M e d i c a l  E q u i p m e n t  ( D M E )  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6    M a r k e t  B r e a k u p  b y  P r o d u c t
    6 . 1     P e r s o n a l  M o b i l i t y  D e v i c e s
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  K e y  S e g m e n t s
           6 . 1 . 2 . 1  W h e e l c h a i r s
           6 . 1 . 2 . 2  S c o o t e r s
           6 . 1 . 2 . 3  W a l k e r  a n d  R o l l a t o r s
           6 . 1 . 2 . 4  C r a n e s  a n d  C r u t c h e s
           6 . 1 . 2 . 5  D o o r  O p e n e r s
           6 . 1 . 2 . 6  O t h e r s
        6 . 1 . 3  M a r k e t  F o r e c a s t
       
    6 . 2     B a t h r o o m  S a f e t y  D e v i c e s  a n d  M e d i c a l  F u r n i t u r e
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  K e y  S e g m e n t s
           6 . 2 . 2 . 1  C o m m o d e s  a n d  T o i l e t s
           6 . 2 . 2 . 2  M a t t r e s s  a n d  B e d d i n g  D e v i c e s
        6 . 2 . 3  M a r k e t  F o r e c a s t
    6 . 3     M o n i t o r i n g  a n d  T h e r a p e u t i c  D e v i c e s
        6 . 3 . 1  M a r k e t  T r e n d s
        6 . 3 . 2  K e y  S e g m e n t s
           6 . 3 . 2 . 1  B l o o d  S u g a r  M o n i t o r s
Table of            6 . 3 . 2 . 2  C o n t i n u o u s  P a s s i v e  M o t i o n  ( C P M )           6 . 3 . 2 . 3  I n f u s i o n  P u m p s
           6 . 3 . 2 . 4  N e b u l i z e r s
           6 . 3 . 2 . 5  O x y g e n  E q u i p m e n t
Contents            6 . 3 . 2 . 6  C o n t i n u o u s  P o s i t i v e  A i r w a y  P r e s s u r e  ( C P A P )           6 . 3 . 2 . 7  S u c t i o n  P u m p s
           6 . 3 . 2 . 8  T r a c t i o n  E q u i p m e n t
           6 . 3 . 2 . 9  O t h e r s
        6 . 3 . 3  M a r k e t  F o r e c a s t
7    M a r k e t  B r e a k u p  b y  E n d  U s e
    7 . 1     H o s p i t a l
        7 . 1 . 1  M a r k e t  T r e n d s
        7 . 1 . 2  M a r k e t  F o r e c a s t
    7 . 2     N u r s i n g  H o m e s
        7 . 2 . 1  M a r k e t  T r e n d s
        7 . 2 . 2  M a r k e t  F o r e c a s t
    7 . 3     H o m e  H e a l t h c a r e
        7 . 3 . 1  M a r k e t  T r e n d s
        7 . 3 . 2  M a r k e t  F o r e c a s t     
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
h t t p s : / / w w w. im a rcg ro u p . co m / d u r a b le - m ed i c a l - eq u ip m e n t - m a r ke t
/ t o c
Disclaimer
© 2023  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145 
E-MAIL: [email protected]